These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16584509)

  • 1. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
    Arlt W; Rosenthal C; Hahner S; Allolio B
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
    Dineen R; Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Keevil BG; Tormey W; Smith D; Thompson CJ; McKenna MJ; Arlt W; Stewart PM; Agha A; Sherlock M
    BMC Endocr Disord; 2020 Oct; 20(1):154. PubMed ID: 33036588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.
    Prete A; Taylor AE; Bancos I; Smith DJ; Foster MA; Kohler S; Fazal-Sanderson V; Komninos J; O'Neil DM; Vassiliadi DA; Mowatt CJ; Mihai R; Fallowfield JL; Annane D; Lord JM; Keevil BG; Wass JAH; Karavitaki N; Arlt W
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2262-74. PubMed ID: 32170323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
    Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
    Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
    Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.
    Barbetta L; Dall'Asta C; Re T; Libè R; Costa E; Ambrosi B
    J Endocrinol Invest; 2005; 28(7):632-7. PubMed ID: 16218046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency.
    Hayashi R; Tamada D; Murata M; Kitamura T; Mukai K; Maeda N; Otsuki M; Shimomura I
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5814-5822. PubMed ID: 31290981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
    Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
    BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K; Thorsen TE; Husebye ES
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
    Jayasena CN; Gadhvi KA; Gohel B; Martin NM; Mendoza N; Meeran K; Dhillo WS
    Clin Chem; 2009 May; 55(5):972-7. PubMed ID: 19282356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring adrenal insufficiency through salivary steroids: a pilot study.
    Tucci L; Fanelli F; Improta I; Bissi V; Lena C; Galante G; Mezzullo M; Magagnoli M; Lalumera AB; Colombin G; Coscia K; Rotolo L; Vicennati V; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2024 Mar; 190(4):327-337. PubMed ID: 38571387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
    Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states.
    Burch WM
    JAMA; 1982 Apr; 247(14):2002-4. PubMed ID: 7062507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.